Stellar Biotechnologies, Inc. 4
4 · Stellar Biotechnologies, Inc. · Filed Dec 23, 2015
Insider Transaction Report
Form 4
OAKES FRANK R.
DirectorPresident, CEO & Director
Transactions
- Gift
Common Shares, without par value
2015-12-22−9,000→ 188,965 total - Exercise/Conversion
Common Shares, without par value
2015-12-22$2.86/sh+4,000$11,440→ 197,965 total
Footnotes (1)
- [F1]Exercise of the security was transacted in Canadian currency and converted to U.S. currency.